Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19
Author(s) -
Eduardo LópezMedina,
Pío López,
Isabel Cristina Hurtado,
Diana Dávalos,
Óscar Ramírez,
Ernesto Martínez,
Jesús Diazgranados,
José Oñate,
Hector Chavarriaga,
Sócrates Herrera,
Beatriz Parra,
Gerardo Andrés Libreros-Zúñiga,
Roberto Jaramillo,
Ana C. Avendaño,
Dilian Francisca Toro,
Miyerlandi Torres,
María Cristina Lesmes,
Carlos Ríos,
Isabella Caicedo-Holguín
Publication year - 2021
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2021.3071
Subject(s) - medicine , interquartile range , ivermectin , placebo , adverse effect , randomized controlled trial , hazard ratio , population , pediatrics , covid-19 , clinical trial , disease , confidence interval , veterinary medicine , environmental health , pathology , infectious disease (medical specialty) , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom